APA

Pietzner K., Vergote I., Santoro A., Chekerov R., Marmé F., Rosenberg P., Martinius H., Friccius-Quecke H. & Sehouli J. (20151026). Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study. : Medical oncology (Northwood, London, England).

Chicago

Pietzner Klaus, Vergote Ignace, Santoro Armando, Chekerov Radoslav, Marmé Frederik, Rosenberg Per, Martinius Holger, Friccius-Quecke Hilke and Sehouli Jalid. 20151026. Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study. : Medical oncology (Northwood, London, England).

Harvard

Pietzner K., Vergote I., Santoro A., Chekerov R., Marmé F., Rosenberg P., Martinius H., Friccius-Quecke H. and Sehouli J. (20151026). Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study. : Medical oncology (Northwood, London, England).

MLA

Pietzner Klaus, Vergote Ignace, Santoro Armando, Chekerov Radoslav, Marmé Frederik, Rosenberg Per, Martinius Holger, Friccius-Quecke Hilke and Sehouli Jalid. Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study. : Medical oncology (Northwood, London, England). 20151026.